Latest News
15,000 signature petition delivered to Number 10 Downing Street
Veteran politician Tony Benn joined actors Mat Fraser and Carol Royle, plus Green MP Dr Caroline Lucas, to present a 15,000 signature petition to Number 10 Downing Street. The Safer Medicines patrons, alongside other MPs, including David Amess (Conservative), Dr Julian Huppert (Liberal Democrat) and Grahame Morris (Labour), are calling for superior new tests based on human biology to be compared with the animal tests currently used to assess the safety of new medicines.
View the presentation here.
Open letter to David Cameron and Andrew Lansley published in The Lancet
Safer Medicines Trust joined forces with 21 senior scientists to call on the Prime Minister and Health Secretary to compare animal tests for drug safety with newer tests based on human biology. Our letter was published in the world's leading medical journal, The Lancet, here.
Sky News covered the story with an excellent report, available here and an interview with Safer Medicines Trust director Kathy Archibald here.
The Daily Mail also reported on the story, here.
Newsletter Autumn 2011 available now
Read our latest newsletter here (pdf)
Second letter published in The Lancet
Predictably, the pro-animal-research lobby attacked our open letter to the Prime Minister and Health Secretary with a response published in The Lancet on 9th July.
We are very pleased that our response to such a false and ill-informed attack was published in The Lancet on 28th October.
Article published on the Science Advisory Board website
Human-Focused Testing to Treat Human Diseases
You can read the article here.
Human Tissues Conference Proceedings published
The proceedings of our Human Tissue Conference, held in the House of Lords in October 2009, have been published as a special edition of the journal Cell & Tissue Banking.
Press Complaints Commission defends Sunday Times' rewriting of medical history
If you were the PCC, how would you defend a newspaper's claim that British Airways, for example, rather than the Wright brothers, pioneered flight? Simple: rewrite the definition of the word "pioneer"!
Incredibly, this is how low those who are charged with upholding standards in the press are willing to stoop in order to defend the media's wilful misrepresentation of facts concerning animal experimentation. This concerns Safer Medicines Campaign because we exist to expose the truth about the best means to discover and develop treatments for patients and to ensure their safety.
The truth is that medical progress is overwhelmingly the result of human clinical observation and studies of human tissues and human disease, rather than research based on animal "models" of human disease. In fact, patients are frequently harmed by reliance on misleading data from animal experimentation. We do not oppose animal experimentation per se but we do believe that it should cease to be given precedence over human-focused testing. Greater focus on research based on human biology would accelerate medical progress and improve the safety of treatments for patients.
But defenders of animal experimentation often claim that medical breakthroughs depended on animal experimentation, refusing to acknowledge that the pivotal discoveries were made in humans (or in vitro) and only later recapitulated in animal models. Their mission is to convince people that animal experimentation is crucial to medical progress. In their eagerness to make their point, truth is often jettisoned in favour of good copy. Editorial codes stipulating accuracy do not appear to apply to this particular topic, as we have found many times.
Public consultation on computer modelling
An EU-funded public consultation on the use of computer modelling as an alternative to animal testing has been launched. The questionnaire is quite short; please take this opportunity to find out more about in silico methods and support their use. The impact of these methods is also discussed in relation to REACH, the EU programme to gather toxicity data on thousands of chemicals. A questionnaire for scientists is also available.
Human Tissues Conference Proceedings published
The Proceedings of our Human Tissues Conference, held in the House of Lords in October 2009, have just been published online by the journal Cell & Tissue Banking! Please contact us or visit the journal website.
The Politics Show (BBC1) interviewed Safer Medicines Director, Sunday 26th September
Kathy Archibald, Director of Safer Medicines Campaign and Safer Medicines Trust, was interviewed live on the Politics Show on Sunday 26th September (East Midlands region). You can watch the programme here, with kind permission of the BBC.
In vitro technology bids for prestigious Innovation 10 prize
Kirkstall, an innovative Sheffield company, has launched a video in support of their bid to win a prestigious Technology Strategy Board prize. Their technology enables different human cell types to be grown in an interconnected way, using a microfluidic flow system. This 'quasi vivo' system more accurately reflects the way in which cells grow in the body, and hence provides more relevant results. We are delighted that Managing Director Dr Malcolm Wilkinson praised our campaign for safer medicines during the course of his video, and wish Kirkstall the best of luck! Winning the £100k prize would enable Kirkstall to develop their technology even further. Please view and rate their entry here (or here). Please note: as only scientific comments are requested, it is perfectly acceptable to vote without commenting!
Newsletter Autumn 2010 available now
Read our latest newsletter here (pdf)
Safety of Medicines Bill and Early Day Motion
Senior Conservative MP David Amess presented the Safety of Medicines Bill to the House of Commons on 20th July. More...
A cross-party group of MPs has also tabled Early Day Motion 475 in support of the Bill.
You can help: please send our postcard to your MP. More...
ASAT Foundation Supports Safer Medicines Initiative
We are delighted that the Dutch Assuring Safety without Animal Testing Foundation has announced its support for our initiative to modernise drug safety testing by conducting a comparison between human biology-based methods and animal tests using a set of drugs known to cause side effects that were not predicted in animals. It is chaired by Dr Bart Sangster, who is also Vice Chair of the Management Board of the European Food Safety Agency. Dr Sangster's illustrious career has included a position as Senior Vice President Safety & Environmental Assurance at Unilever, a professorship in Clinical Toxicology at the University of Utrecht, and posts as Head of the Poison Control Centre at the National Institute for Public Health & the Environment and the Intensive Care Department of the University Hospital Utrecht.
Support from election candidates
We contacted hundreds of new parliamentary candidates in the run-up to the election in order to find out whether they would support the modernisation of drug safety testing. The responses we received were almost unanimously supportive: only Ben Gummer (now MP for Ipswich) did not support our proposal. See all responses here
